On September 14, 2023, Camac Partners, LLC and ATG Capital Management, LLC announced that independent proxy advisory firms Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC have recommended stockholders support boardroom change at Forte Biosciences, Inc.?s upcoming annual meeting of stockholders scheduled for September 19, 2023. Camac Partners and ATG Capital Management stated that ISS and Glass Lewis conclude the Company?s poor performance and dilutive, anti-stockholder actions under chairman and CEO Paul Wagner?s leadership indicate Boardroom change is urgently needed. Camac Partners and ATG Capital Management added that Glass Lewis recommends stockholders vote for their director candidates ?

Michael Hacke and Chris McIntyre. Camac Partners and ATG Capital Management also stated that Glass Lewis acknowledges the Company?s entrenched board is in dire ?Need of Fresh Perspectives,? necessitating Chairman and CEO Paul Wagner and Lawrence Eichenfield?s removal.